# Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects

> **NCT01297582** · PHASE1 · COMPLETED · sponsor: **Ono Pharma USA Inc** · enrollment: 56 (actual)

## Conditions studied

- Healthy Adult Subjects

## Interventions

- **DRUG:** ONO-6950
- **DRUG:** ONO-6950

## Key facts

- **NCT ID:** NCT01297582
- **Lead sponsor:** Ono Pharma USA Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-06
- **Final completion:** —
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2012-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01297582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01297582, "Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01297582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*